Atlas Trials

Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis

Clinical trial NCT04159870 · UNKNOWN

Trial details

NCT number
NCT04159870
Sponsor
Ospedali Riuniti di Foggia
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Spontaneous Bacterial Peritonitis
Start date
2019-11-05
Primary completion
2021-11-20
Enrollment
322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.